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MR Imaging in Patients With
Pacemakers and Other Devices
Engineering the Future
The rapid proliferation of diagnostic and therapeuticmodalities using
a spectrumofmaterials and energy sources has led to the potential for
interactions that limit or contraindicate the use of magnetic reso-
nance imaging (MRI). This convergence of technologies in patient
care due to the frequent use of MRI procedures requires biomedical
implant developers to engineer and prospectively study mechanisms
to protect against unwanted interactions. The design of a cardiac
pacemakerwith special attention to theMRI environment represents
a paradigm shift in device engineering.
Initial studies of pacemaker/MRI interactions occurred
through in vitro experimentation, retrospective case reports, and
series of patients with pacemakers accidentally or intentionally
placed in the MRI environment (1). Subsequently, prospective
studies of carefully monitored patients with pacemakers examined
using MRIs under well-defined conditions yielded variable re-
sults, as electromagnetic energy conduction can potentially cause
tissue damage at the lead tip/endocardial interface, damage to the
pulse generator and leads affecting sensing and pacing threshold
Table 1. Study Factors for the MR-Conditional Pacemaker Available i
[Medtronic, Inc., Minneapolis, Minnesota]) (3)
MR system Horizontal, cylindrical bore magnet, clinical
Gradient magnetic ﬁelds Gradient systems with maximum gradient
RF energy/SAR Scanner in normal operating mode:
Whole body–averaged SAR as reported by
The head SAR must be 3.2 W/kg.
Patient screening Patients and their implanted systems scree
The implanted system consisted solely of a
a hazard to the patient during MRI scan
No previously implanted (active or abando
No broken leads or leads with intermittent
A SureScan pacing system implanted for a
A SureScan pacing system implanted in the
Pacing capture threshold values 2.0 V at
A lead impedance value 200  and 1,5
No diaphragmatic stimulation at a pacing o
were programmed to an asynchronous p
Patient positioning The patient positioned within the bore suc
or inferior to the T12 vertebra.
Patient monitoring Proper patient monitoring during the MRI
electrocardiography, and pulse oximetry
Pacemaker staff A healthcare professional with completed c
SureScan feature.
Imaging staff A healthcare professional with completed r
Results Patients with the MR-conditional pacemake
Through 1-month follow-up compared with
No reported arrhythmias (asystole, sustaine
reset, inhibition of generator output, or
No signiﬁcant changes in pacing parameteMR  magnetic resonance; MRI  magnetic resonance imaging; RF  radiofrequency; SAnd impedances, inappropriate pacing acceleration or inhibition,
attery depletion, and other issues (1).
Challenges regarding the risks of performing MRI examinations
ersus the potential benefits to individual patients in situations in
hich anMRIwas essential to patientmanagement (1,2) have led to
he first wave of engineering of prospectively designed pacing systems
cceptable for use under specificMRI and device conditions (3,4). A
magnetic resonance [MR]-conditional” item is defined as posing no
nown hazards in a specified MRI environment with specified
onditions of use; an “MR-safe” item as posing no known hazards in
ll MRI environments; and an “MR-unsafe” item as posing hazards
n all MRI environments (5).
Currently, there is only 1 published prospective, randomized
ulticenter study assessing the efficacy and safety of a pacing
ystem engineered to be MR conditional (3). Pulse generator
esign changes included: 1) reducing ferromagnetic content to
inimize magnetic field interactions and to avoid damage or
alfunction of components; 2) shielding to minimize the effect of
he electromagnetic environments; and 3) changing the reed
witch to a Hall sensor, which allows for predictable behavior in
magnetic field. The lead wire winding pattern was designed to
inimize potential heating of the pacing system and cardiac
issue due to conduction of electrical impulses from time-varying
agnetic fields and radiofrequency energy from the MR scanner
o the pacing lead. Dedicated programming modes include
e United States (Revo MRI SureScan Pacing System
I systems with a static magnetic ﬁeld of 1.5-T must be used.
rate performance per axis of 200-T/m/s must be used.
MRI equipment of 2.0 W/kg.
to meet the following requirements:
eScan device and SureScan leads. Any other combination may result in
) medical devices, leads, lead extenders, or lead adaptors.
trical contact as conﬁrmed by using lead impedance history.
imum of 6 weeks.
t or right pectoral region.
lse width of 0.4 ms.
.
ut of 5.0 V and at a pulse width of 1.0 ms in patients whose devices
g mode when MRI SureScan is on.
at the isocenter (center of the MRI bore) is superior to the C1 vertebra
. The methods included visual and verbal contact with the patient,
plethysmography).
iology SureScan training present during the programming of the
logy SureScan training present during the MRI scan.
derwent MRI (N  226).
ntrols:
ntricular arrhythmias, or unexpected changes in heart rate), electrical
ations (related to magnetic ﬁeld interactions or pain).
ensing, threshold, or impedance change) compared with controls.n th
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Letter to the Editor 333asynchronous (5.0 V/1.0 ms) pacing and nonstimulation choices.
Labeling to identify the device and components as MR conditional
include radio-opaque markings on the pulse generator, leads with a
unique radio-opaque indicator, and identification cards with an MR-
conditional icon and information. Study conditions and results are
listed in Table 1. Importantly, no significant complications were
observed in this study. Further post-marketing data will help define
potential issues with application to larger groups of patient in other
clinical settings.
Three medical device companies (Biotronik, Berlin, Germany;
Medtronic, Inc., Minneapolis, Minnesota; and St. Jude Medical,
St. Paul, Minnesota) have MR-conditional cardiac pacemakers
available in Europe and other countries. In the United States, the
U.S. Food and Drug Administration approved the Revo MRI
SureScan Pacing System (Medtronic, Inc.). Because the leads and
pulse generator technology were specifically designed for use in 1
integrated system, these systems are not indicated for generator
changes using pre-existing leads or situations in which abandoned
leads are still present in the patient. Currently, in the United States,
the Medtronic, Inc. system has scan-positioning limitations (land-
mark isocenter of radiofrequency coil superior to C1 or inferior to
T12), whereas in Europe, MR-conditional pacemaker isocenter
conditions include: Medtronic (no scan exclusion zone), St. Jude
Medical (contraindication to use of transmit radiofrequency coil
directly over the pacing system) and Biotronik (scan exclusion zone
with the maximum allowed positioning mark for the isocenter
starting from the foot at the hip level and the maximum allowed
positioning mark for the isocenter from the top of the skull at the
level of the eyes). Because there are no specific guidelines regarding
scanning beyond the specified limitations of an individual MR-
conditional device, reliance on the current literature and the
guidance of institutional review bodies regarding the risks and
benefits in these situations are important considerations (1,2).
The spectrum of electronically activated biomedical devices with
otential MRI interactions has significantly increased and includes
mplantable cardioverter-defibrillators, resynchronization devices,
oop memory recorders, implantable physiological measurement
evices, and neuromodulation devices. Similar design, engineering,
nd prospective testing will be required for these devices relative to
se in patients undergoing MRI procedures.
The current MR-conditional pacemakers provide an important
tep in device engineering, allowing patients to have greater access
o what is considered to be one of the most important noninvasive
iagnostic imaging procedures: the MRI. Future questions relate to
ow to safely and cost-effectively engineer, evaluate, and implement
ew MR-conditional systems (Table 2). A continued multidisci-
linary approach directed toward understanding the interface of
edical devices, diagnostic imaging studies, therapeutic procedures,
nd environmental energy exposures is required to prevent or
inimize adverse interactions related to the convergence of theseechnologies.Jerold S. Shinbane, MD,* Patrick M. Colletti, MD,
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Table 2. Future Goals for Development and Evaluation of
MR-Conditional Cardiac Devices
Development of:
Cardiac devices and conﬁgurations in addition to single- and dual-chamber
pacemakers for MR-conditional use.
MR scanner technologies and imaging sequences to further prevent
interactions with devices.
Alternative imaging modalities for indications in which MRI is currently the
gold standard.
Educational modules on the speciﬁc conditions for each device as they are
approved.
Multidisciplinary algorithms for the MRI facility for safety and efﬁciency of
imaging patients with cardiac and other devices.
Algorithms for assessing acute to subacute MRI needs before device
placement if MRI may limit the ability to perform these studies after
device placement.
Research evaluation of:
Use of MR-conditional cardiac devices with other clinically relevant static
magnetic ﬁeld strengths (e.g., 3-T MR systems).
Further assessment of isocenter limitations related to chest/cardiac imaging
safety issues and MRI artifacts.
MR-conditional device platforms versus standard device platforms, assessing:
Utility of MR-conditional platforms in speciﬁc situations or patient
populations versus use as standard cardiac pacemaker platforms.
Cost-effectiveness of MR-conditional platforms versus standard cardiac
pacemaker platforms.
Use of MR-conditional cardiac devices with interventional and cardiac
electrophysiology laboratory MRI real-time imaging systems for
procedural guidance.
Abbreviations as in Table 1.and devices: explanation of terminology. Radiology 2009;253:26–30.
